These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26756465)

  • 21. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher.
    Lin YJ; Chao TF; Tsao HM; Chang SL; Lo LW; Chiang CE; Hu YF; Hsu PF; Chuang SY; Li CH; Chung FP; Chen YY; Wu TJ; Hsieh MH; Chen SA
    Europace; 2013 May; 15(5):676-84. PubMed ID: 23193161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Atrial Fibrillation With Incidence of Extracranial Systemic Embolic Events: The ARIC Study.
    Shi M; Chen LY; Bekwelem W; Norby FL; Soliman EZ; Alam AB; Alonso A
    J Am Heart Assoc; 2020 Sep; 9(18):e016724. PubMed ID: 32865122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
    Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
    Aronis KN; Zhao D; Hoogeveen RC; Alonso A; Ballantyne CM; Guallar E; Jones SR; Martin SS; Nazarian S; Steffen BT; Virani SS; Michos ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.
    Magnani JW; Norby FL; Agarwal SK; Soliman EZ; Chen LY; Loehr LR; Alonso A
    JAMA Cardiol; 2016 Jul; 1(4):433-41. PubMed ID: 27438320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship among atrial fibrillation, the CHA
    Shi B; Liu D; Wang Q; Geng X; Hou Q; Gu G; Xie R; Cui W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):474. PubMed ID: 34600490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of lipoprotein-associated phospholipase A
    Garg PK; Bartz TM; Norby FL; Jorgensen NW; McClelland RL; Ballantyne CM; Chen LY; Gottdiener JS; Greenland P; Hoogeveen R; Jenny NS; Kizer JR; Rosenson RS; Soliman EZ; Cushman M; Alonso A; Heckbert SR
    Am Heart J; 2018 Mar; 197():62-69. PubMed ID: 29447785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body mass index and adverse events in patients with incident atrial fibrillation.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Lip GY; Larsen TB
    Am J Med; 2013 Jul; 126(7):640.e9-17. PubMed ID: 23601271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of cigarette smoking in predicting stroke using CHADS
    Zuo ML; Li CM; Deng Y; Bhattacharyya S; Shuai P; Tse HF; Siu CW; Yin LX
    Neurol Sci; 2021 Jan; 42(1):159-166. PubMed ID: 32572660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
    Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
    Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation.
    Wei-Syun Hu ; Lin CL
    Lupus; 2018 Jul; 27(8):1240-1246. PubMed ID: 29554836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study.
    Nielsen PB; Overvad TF; Andersen SD; Larsen TB; Skjøth F; Søgaard M; Lip GYH
    Cerebrovasc Dis; 2019; 48(3-6):236-243. PubMed ID: 31846970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study.
    Chen LY; Sotoodehnia N; Bůžková P; Lopez FL; Yee LM; Heckbert SR; Prineas R; Soliman EZ; Adabag S; Konety S; Folsom AR; Siscovick D; Alonso A
    JAMA Intern Med; 2013 Jan; 173(1):29-35. PubMed ID: 23404043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The QT interval and risk of incident atrial fibrillation.
    Mandyam MC; Soliman EZ; Alonso A; Dewland TA; Heckbert SR; Vittinghoff E; Cummings SR; Ellinor PT; Chaitman BR; Stocke K; Applegate WB; Arking DE; Butler J; Loehr LR; Magnani JW; Murphy RA; Satterfield S; Newman AB; Marcus GM
    Heart Rhythm; 2013 Oct; 10(10):1562-8. PubMed ID: 23872693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project.
    Sciacqua A; Perticone M; Tripepi G; Tassone EJ; Cimellaro A; Mazzaferro D; Sesti G; Perticone F
    Intern Emerg Med; 2015 Oct; 10(7):815-21. PubMed ID: 25939338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.